Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01570712
Other study ID # 2011-A00668-33
Secondary ID 2011-12
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 2011
Est. completion date June 2019

Study information

Verified date September 2018
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As mental health care shifted from state psychiatric hospitals to the community in France and western countries, the mental health system became inevitably involved in housing as it strove to meet the broader psychosocial needs of consumers. Simultaneously, as many consumers found themselves unable to find stable living in the community and struggling with addictions, they became a significant subgroup within a larger homeless population, which has received increasing policy attention over the past three decades. There are two distinct service models for adults who have severe mental illness and are homeless: the residential continuum model and the Housing First model.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 600
Est. completion date June 2019
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

aged over 18;

- who are absolutely homeless or precariously housed. Absolutely homeless is defined as having had no fixed place to stay for at least the past seven nights with little likelihood of finding a place in the coming month. Precariously housed is defined as being housed a in single room occupancy, rooming house, or hotel/motel as a primary residence AND in the past year having experienced two or more episodes of being absolutely homeless OR one episode of being absolutely homeless that lasted for more than four weeks in the preceding 12 months.

- living with schizophrenia or bipolar disorder (diagnosis of DSM-IV);

- with a sufficient understanding of written and spoken French to be able to provide informed consent and to participate to face-to-face interviews;

- affiliated to a social protection;

- who have lived in the city targeted for at least 6 months and willing to stand in the city during the 2 next years;

- with a global score measured on Multnomah Community Ability Scale (MCAS) (scale <=62 (high need criteria));

- hospitalized at least twice on the past 12 months OR held in prison on the past 24 months OR presenting substance or alcohol abuse or dependence (high need criteria).

Exclusion Criteria:

- being considered unable to provide informed consent;

- having dependent children;

- pregnancy;

- or a DSM-IV Axis I diagnosis other than schizophrenia or bipolar disorder

Study Design


Intervention

Other:
HOUSING FIRST PROGRAM
Realization of a psychosocial organic evaluation and a citizen; Support in the development and the maintenance of the housing; Support in the diverse steps (administrative, judicial, financiers, etc.); Support around addictions / alcohol; Supportin the family and social relations, in the environment of the person -to favor the occupational integration, by prioritizing the insertion in ordinary environment(middle) to favor the access and the preservation of the patient to the psychiatric and somatic care, to the devices and the departments favoring the social insertion and the integration.
traditional French services
The person will not receive from intervention of the team of site, but the person can resort(turn) without limitation to all the range of services said " about "common law " set up in the direction of the persons homeless persons, as well as to every type of care. She can too reach the housing and\or the restoring, but this by means of the existing devices

Locations

Country Name City State
France Assistance Publique Hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary healthcare utilisation hospitalizations, hospital days, and emergency department visits 3 YEARS